Global Pediatric Palliative Care Drugs Market: Restraints
Less research and development in palliative care disease treatment
The less research and development in palliative care disease treatment is expected to hamper the global pediatric palliative care drugs market growth. For instance, according to an article published by Journal JAMA Health Forum on January 28, 2022, the less number of study population is due to ethical issues in pediatric research which reduces pediatric research and development activities. Also poor outcomes, high costs, and persistent inequities for serious medical illness suggests substantial room for improvement.
To counterbalance this restraint, a more research and development using computational models should be carried out.
Lack of awareness about palliative care
In emerging economies, lack of awareness about palliative care is expected to hamper the global pediatric palliative care drugs market growth. For instance, according to an article published in Journal American Journal of Hospice and Palliative Medicine on February 4, 2021, a study was conducted to examine correlates of awareness of palliative, hospice care and advance directives in a racially and ethnically diverse large sample of adults in California, U.S. The study included 2,328 adults. The study concluded that 75% of Hispanics participants claimed that they have never heard about palliative care. Multivariate analysis of data show gender, age, education, and income all significantly were associated with awareness.
To counterbalance this restrain, more awareness programs should be conducted about palliative care.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients